Condition
Stage II Bladder Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Stage II Bladder Cancer AJCC v8 clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Canada (1)). By phase: Phase 2 (2), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Stage II Bladder Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ctDNA-based monitoring in muscle-invasive bladder cancer | — | Portland, Oregon | Recruiting | Jul 24, 2026 |
| Shorter-course versus standard-course radiation with chemotherapy for muscle-invasive bladder cancer | Phase 3 | Fairbanks, Alaska and 258 other locations | Recruiting | Jul 31, 2025 |
| Immunotherapy plus radiation to avoid bladder removal after chemo for muscle-invasive bladder cancer | Phase 2 | Birmingham, Alabama and 181 other locations | Recruiting | Jul 14, 2025 |
| Combining enfortumab vedotin and pembrolizumab with radiation for muscle invasive bladder cancer | Phase 1/2 | San Francisco, California | Recruiting | Jun 24, 2024 |
| Combining futibatinib and durvalumab before bladder cancer surgery for patients who can't use cisplatin | Phase 2 | Ann Arbor, Michigan and 2 other locations | Recruiting | Feb 16, 2024 |
All recruiting trials (5)
-
ctDNA-based monitoring in muscle-invasive bladder cancer
This study tests whether a blood-based ctDNA test can flag residual or returning disease in adults with muscle-invasive bladder cancer undergoing standard treatments.
-
Shorter-course versus standard-course radiation with chemotherapy for muscle-invasive bladder cancer
This trial tests whether a much shorter course of radiation plus standard chemotherapy works as well as the usual shorter radiation schedule for people with muscle-invasive bladder cancer who are pursuing bladder-preserving treatment.
-
Immunotherapy plus radiation to avoid bladder removal after chemo for muscle-invasive bladder cancer
This phase II test gives pembrolizumab with radiation after chemotherapy to try to help people with muscle-invasive bladder cancer keep their bladders instead of having them removed.
-
Combining enfortumab vedotin and pembrolizumab with radiation for muscle invasive bladder cancer
This study is testing a new combination of a drug and radiation therapy to see if it helps people with muscle invasive bladder cancer who want to avoid surgery.
-
Combining futibatinib and durvalumab before bladder cancer surgery for patients who can't use cisplatin
This study is testing if combining two drugs, futibatinib and durvalumab, before bladder cancer surgery can help patients who can't take cisplatin feel better and improve their chances of recovery.
Related topics
Quick answers
How many Stage II Bladder Cancer AJCC v8 clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.